glp-1 drugs alzheimer's How GLP-1s Could Transform Treatment GLP-1 Agonists as Therapeutics for

doi: 10.1021/acs.jproteome.0c00282

4 Intermittent fasting in the era of obesity pharmacotherapy From a therapeutic perspective, the controversy surrounding the health outcomes of IF should also be considered in the context of the evolving development of novel anti-obesity and anti-diabetic medications

Carrying extra weight is a serious health concern for domestic cats , with excess pounds affecting a substantial portion of our feline companions and leading to numerous potential complications

[,] Accordingly, one of the well-known related factors is the increased cytokine production due to inflammation, resulting in increased oxidative stress in the patients body